We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

96 hedge funds and large institutions have $13.9M invested in Vaxart in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 30 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,340% more call options, than puts

Call options by funds: $216K | Put options by funds: $15K

9.18% less ownership

Funds ownership: 21.34% → 12.16% (-9.2%)

14% less funds holding

Funds holding: 111 → 96 (-15)

34% less capital invested

Capital invested by funds: $21.1M → $13.9M (-$7.19M)

37% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 30

65% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 23

Holders
96
Holders Change
-15
Holders Change %
-13.51%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
19
Reduced
30
Closed
23
Calls
$216K
Puts
$15K
Net Calls
+$201K
Net Calls Change
+$59K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$205K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$166K
3
PPP
Private Portfolio Partners
New Jersey
+$84.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$47.5K
5
AWM
AE Wealth Management
Kansas
+$30.4K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$4.01M
2
Renaissance Technologies
Renaissance Technologies
New York
-$576K
3
Citadel Advisors
Citadel Advisors
Florida
-$566K
4
Millennium Management
Millennium Management
New York
-$427K
5
RCMU
Rokos Capital Management (UK)
United Kingdom
-$365K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$2K -$3.77K -4,950 -60%
HI
77
Harbour Investments
Wisconsin
$1.14K – – –
UBS Group
78
UBS Group
Switzerland
$900 -$1.52K -2,002 -63%
CSPIA
79
Cary Street Partners Investment Advisory
Virginia
$754 – – –
AF
80
Advisornet Financial
Minnesota
$528 – – –
CTC
81
Central Trust Company
Missouri
$377 – – –
JP Morgan Chase
82
JP Morgan Chase
New York
$339 – – –
MIM
83
Macroview Investment Management
Maryland
$273 – – –
BCWM
84
Bartlett & Co Wealth Management
Ohio
$151 – – –
PA
85
PSI Advisors
Florida
$151 – – –
LFG
86
Larson Financial Group
Missouri
$118 – – –
GIA
87
GHP Investment Advisors
Colorado
$107 – – –
Toronto Dominion Bank
88
Toronto Dominion Bank
Ontario, Canada
$93 – – –
UB
89
UMB Bank
Missouri
$75 – – –
CWP
90
Concord Wealth Partners
Virginia
$57 – – –
TWC
91
TD Waterhouse Canada
Ontario, Canada
$35 – – –
PPWM
92
PFG Private Wealth Management
Florida
$23 +$23 +30 New
AIC
93
Archer Investment Corporation
Indiana
$11 – – –
Citigroup
94
Citigroup
New York
$2 – – –
RCMU
95
Rokos Capital Management (UK)
United Kingdom
– -$365K -500,000 Closed
YIH
96
Y-Intercept (HK)
Hong Kong
– -$158K -216,851 Closed
Two Sigma Advisers
97
Two Sigma Advisers
New York
– -$131K -179,900 Closed
VF
98
Virtu Financial
New York
– -$108K -148,213 Closed
HF
99
HRT Financial
New York
– -$88K -120,834 Closed
LCM
100
Laurion Capital Management
New York
– -$59K -80,843 Closed
1 2 3
4
5

VXRT Hedge Fund Activity: Q3 2023 in Review

96 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2023, worth a combined $13.9M — down 34% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VXRT and 8 opened new positions — a net loss of 15 holders — while 30 trimmed existing stakes and 19 added.

The largest buyer was GSA Capital Partners, adding an estimated $205K. The largest seller was Cantor Fitzgerald, cutting an estimated $4.01M.

  • 96 institutional investors held Vaxart (VXRT) as of Q3 2023, down from 111 in Q2 2023.
  • Funds reported $13.9M of Vaxart stock for Q3 2023, down 34% quarter-over-quarter.
  • 8 funds opened new Vaxart positions in Q3 2023 and 23 closed out, a net change of -15 holders.
  • The largest Vaxart buyer in Q3 2023 was GSA Capital Partners, an estimated $205K added.
  • The largest Vaxart seller in Q3 2023 was Cantor Fitzgerald, an estimated $4.01M sold.

Based on aggregated 13F filings for Q3 2023.